PROGRAM

Third Congress of the Macedonian Hematology Association with international participation

Location of the meeting: Hotel Double Tree by Hilton - Skopje

Day 1: September 12, 2023 (Tuesday)
12:00-13:00 Registration
13:00-13:45 PHARMACEUTICAL INDUSTRY SYMPOSIUM 1
13:45-14:30 PHARMACEUTICAL INDUSTRY SYMPOSIUM 2
14:30-15:30 Opening ceremony and welcome drink
15:30-16:45 GENERAL SESSION 1: How I treat Non Hodgkin lymphomas (NHL)
16:45-17:05 GENERAL SESSION 2: How I treat Hodgkin lymphomas (HL)
18:00-18:15 Coffee break
18:15-18:40 PLENARY LECTURE 1: Future of the leukemia research
19:00-20:30 PHARMACEUTICAL INDUSTRY SYMPOSIUM 3
   

Day 2: September 13, 2023 (Wednesday)
09:00-09:45 PHARMACEUTICAL INDUSTRY SYMPOSIUM 4
09:45-10:30 PHARMACEUTICAL INDUSTRY SYMPOSIUM 5
10:30-10:45 Coffee break
10:45-12:05 GENERAL SESSION 3: How I treat Chronic Lymphocytic Leukemia (CLL)
12:05-13:25 GENERAL SESSION 4: How I treat Multiple Myeloma (MM)
13:25-13:50 PLENARY LECTURE 2: CAR T-cell therapy in multiple myeloma
13:50-14:30 Lunch
14:30-15:50 GENERAL SESSION 5: How I treat chronic myeloid leukemia (CML) and BCR/ABL negative myeloproliferative neoplasm (MPN)
15:50- 17:10 GENERAL SESSION 6: State of art treatment of AML & MDS-MD
17:10-17:25 Coffee break
17:25- 18:20 Poster viewing and oral presentation of the 3 best posters
18:20-19:05 PHARMACEUTICAL INDUSTRY SYMPOSIUM 6
19:05-19:50 PHARMACEUTICAL INDUSTRY SYMPOSIUM 7
20:30-22:30 GALA DINNER
   

Day 3: September 14, 2023 (Thursday)
09:00-09:45 PHARMACEUTICAL INDUSTRY SYMPOSIUM 8
09:45-10:30 PHARMACEUTICAL INDUSTRY SYMPOSIUM 9
10:30-10:45 Coffee break
10:45-12:05 GENERAL SESSION 7: State of art treatment in oncology and radiotherapy
12:05-13:25 GENERAL SESSION 8: State of art treatment of cancer associated thrombosis and emergencies in hematology
13:25-14:10 Lunch
14:10-14:40 PLENARY LECTURE 3: CURRENT TREATMENT RECOMMENDATION FOR ALL
14:40-16:00 GENERAL SESSION 9: PEDIATRIC HEMATOLOGY
16:00-18:00 GENERAL SESSION 10: HEMATOPOIETIC STEM CELL TRANSPLANTATION
   
18:00 Closing of the congress: ADJOURN